This inventor holds 1 USPTO granted patent. Top assignee: Neurocal International Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: James David Adams: Innovator in Neural Trauma Treatment
Introduction
James David Adams is a notable inventor based in La Crescenta, California. He has made significant contributions to the field of medical science, particularly in the treatment of neural trauma. His innovative approach focuses on the use of NAD-related compounds to mitigate neural degeneration.
Latest Patents
James David Adams holds a patent for the "Use of NAD-related compounds in the treatment of neural trauma." This invention is directed towards methods for reducing the degree of neural degeneration in mammals due to acute neural trauma. The administration of NAD-related compounds, such as nicotinamide adenine dinucleotide (NAD) and its various forms, plays a crucial role in this method.
Career Highlights
Adams is associated with Neurocal International Inc., where he applies his expertise in developing therapeutic solutions. His work is pivotal in advancing treatments that address critical health issues related to neural trauma.
Collaborations
Some of his notable coworkers include Lori Kathleen Klaidman and Suman Kumar Mukherjee, who contribute to the innovative environment at Neurocal International Inc.
Conclusion
James David Adams exemplifies the spirit of innovation in the medical field, particularly through his work on NAD-related compounds for neural trauma treatment. His contributions are vital for advancing therapeutic methods that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile